宜安科技(300328.SZ)擬向寧德三祥銷售10台液態金屬機器設備
格隆匯4月8日丨宜安科技(300328.SZ)公佈,2020年4月8日,公司(“乙方”)與寧德三祥液態金屬科技有限公司(“寧德三祥”或“甲方”)共同簽署了《設備買賣合同》,寧德三祥同意向宜安科技採購10台兩種型號規格的液態金屬機器設備,總金額為人民幣3080萬元。
此次設備買賣合同的簽訂,一方面增加了參股公司寧德三祥的液態金屬設備產能,為其逐步導入液態金屬技術並量產液態金屬產品做鋪墊,另一方面滿足了液態金屬行業發展規模日益擴大的需求,延伸公司液態金屬產業鏈,推動液態金屬產業發展,增強公司綜合競爭力,符合公司發展戰略。此次設備買賣合同對公司財務狀況、經營成果將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.